Investment Analysts’ price target changes for Thursday, August 13th:
Advance Auto Parts (NYSE:AAP) had its price target increased by Royal Bank Of Canada from $65.00 to $67.00. They currently have a sector perform rating on the stock.
AECOM (NYSE:ACM) had its price target reduced by Royal Bank Of Canada from $105.00 to $90.00. They currently have an outperform rating on the stock.
Amplitude (NASDAQ:AMPL) had its target price increased by Morgan Stanley from $12.00 to $16.00. They currently have an overweight rating on the stock.
Andersen Group (NYSE:ANDG) had its target price raised by Robert W. Baird from $44.00 to $57.00. The firm currently has an outperform rating on the stock.
Andersen Group (NYSE:ANDG) had its price target boosted by Truist Financial Corporation from $42.00 to $55.00. They currently have a buy rating on the stock.
Andersen Group (NYSE:ANDG) had its target price boosted by Wells Fargo & Company from $38.00 to $49.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Alto Neuroscience (NYSE:ANRO) had its price target increased by Wedbush from $24.00 to $26.00. They currently have a neutral rating on the stock.
Alto Neuroscience (NYSE:ANRO) had its price target boosted by BTIG Research from $28.00 to $37.00. The firm currently has a buy rating on the stock.
Alpha and Omega Semiconductor (NASDAQ:AOSL) had its price target reduced by Needham & Company LLC from $50.00 to $45.00. Needham & Company LLC currently has a buy rating on the stock.
Alpha and Omega Semiconductor (NASDAQ:AOSL) had its price target cut by B. Riley Financial, Inc. from $38.00 to $34.00. The firm currently has a neutral rating on the stock.
Aprea Therapeutics (NASDAQ:APRE) had its price target cut by Wedbush to $3.00. They currently have an outperform rating on the stock.
Aramark (NYSE:ARMK) had its target price increased by JPMorgan Chase & Co. from $55.00 to $70.00. The firm currently has an overweight rating on the stock.
Anterix (NASDAQ:ATEX) had its target price reduced by JPMorgan Chase & Co. from $133.00 to $130.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Aviva (LON:AV) had its price target boosted by JPMorgan Chase & Co. from GBX 715 to GBX 800. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Axos Financial (NYSE:AX) had its price target increased by Benchmark Co. from $115.00 to $120.00. The firm currently has a buy rating on the stock.
Balfour Beatty (LON:BBY) had its target price raised by Berenberg Bank from GBX 870 to GBX 1,070. The firm currently has a buy rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its target price raised by Royal Bank Of Canada from $180.00 to $190.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its price target reduced by Keefe, Bruyette & Woods from $14.00 to $10.00. They currently have a market perform rating on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its price target cut by B. Riley Financial, Inc. from $23.00 to $21.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
BTGO (NYSE:BTGO) had its target price lowered by Wedbush from $15.00 to $8.00. The firm currently has an outperform rating on the stock.
BTGO (NYSE:BTGO) had its target price trimmed by Rosenblatt Securities from $15.00 to $10.00. Rosenblatt Securities currently has a buy rating on the stock.
BTGO (NYSE:BTGO) had its price target lowered by Wells Fargo & Company from $13.00 to $11.00. They currently have an overweight rating on the stock.
Cardinal Health (NYSE:CAH) had its target price increased by JPMorgan Chase & Co. from $215.00 to $260.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Cerebras Systems (NASDAQ:CBRS) had its price target reduced by Mizuho from $310.00 to $300.00. Mizuho currently has an outperform rating on the stock.
Cerebras Systems (NASDAQ:CBRS) had its price target raised by Wedbush from $280.00 to $290.00. The firm currently has an outperform rating on the stock.
Chemours (NYSE:CC) had its price target cut by BMO Capital Markets from $26.00 to $18.00. BMO Capital Markets currently has an outperform rating on the stock.
Chemours (NYSE:CC) had its price target reduced by JPMorgan Chase & Co. from $22.00 to $15.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its price target lowered by Royal Bank Of Canada from $18.00 to $12.00. The firm currently has a sector perform rating on the stock.
Cullinan Therapeutics (NASDAQ:CGEM) had its price target increased by Wedbush from $39.00 to $42.00. Wedbush currently has an outperform rating on the stock.
Americold Realty Trust (NYSE:COLD) had its target price increased by Scotiabank from $15.00 to $16.00. They currently have a sector perform rating on the stock.
Camden Property Trust (NYSE:CPT) had its price target increased by JPMorgan Chase & Co. from $113.00 to $114.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Salesforce (NYSE:CRM) had its target price boosted by Monness Crespi & Hardt from $200.00 to $222.00. Monness Crespi & Hardt currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Rosenblatt Securities from $150.00 to $165.00. The firm currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price boosted by Morgan Stanley from $130.00 to $135.00. Morgan Stanley currently has an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by KeyCorp from $130.00 to $135.00. The firm currently has an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Barclays PLC from $121.00 to $123.00. They currently have an equal weight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target raised by Truist Financial Corporation from $125.00 to $140.00. Truist Financial Corporation currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Wells Fargo & Company from $130.00 to $150.00. Wells Fargo & Company currently has an overweight rating on the stock.
CytomX Therapeutics (NASDAQ:CTMX) had its price target cut by JPMorgan Chase & Co. from $12.00 to $11.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its price target increased by JPMorgan Chase & Co. from $97.00 to $103.00. The firm currently has an overweight rating on the stock.
Dominion Energy (NYSE:D) had its price target reduced by Truist Financial Corporation from $68.00 to $66.00. They currently have a hold rating on the stock.
Definium Therapeutics (NASDAQ:DFTX) had its target price raised by Royal Bank Of Canada from $57.00 to $66.00. They currently have an outperform rating on the stock.
Definium Therapeutics (NASDAQ:DFTX) had its price target boosted by Wells Fargo & Company from $68.00 to $72.00. The firm currently has an overweight rating on the stock.
Definium Therapeutics (NASDAQ:DFTX) had its target price raised by Robert W. Baird from $57.00 to $75.00. The firm currently has an outperform rating on the stock.
Healthpeak Properties (NYSE:DOC) had its target price boosted by Robert W. Baird from $21.00 to $24.00. They currently have an outperform rating on the stock.
Brinker International (NYSE:EAT) had its target price raised by Mizuho from $175.00 to $275.00. They currently have an outperform rating on the stock.
Brinker International (NYSE:EAT) had its target price boosted by Stephens from $220.00 to $300.00. The firm currently has an overweight rating on the stock.
Brinker International (NYSE:EAT) had its price target boosted by KeyCorp from $204.00 to $275.00. They currently have an overweight rating on the stock.
Brinker International (NYSE:EAT) had its target price raised by DA Davidson from $160.00 to $260.00. They currently have a neutral rating on the stock.
Brinker International (NYSE:EAT) had its price target raised by BMO Capital Markets from $175.00 to $230.00. They currently have a market perform rating on the stock.
Brinker International (NYSE:EAT) had its price target boosted by Wells Fargo & Company from $220.00 to $280.00. Wells Fargo & Company currently has an overweight rating on the stock.
Brinker International (NYSE:EAT) had its target price boosted by Morgan Stanley from $207.00 to $250.00. The firm currently has an overweight rating on the stock.
Everus Construction Group (NYSE:ECG) had its price target reduced by Cantor Fitzgerald from $174.00 to $152.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Enovix (NASDAQ:ENVX) had its target price reduced by B. Riley Financial, Inc. from $10.00 to $9.00. They currently have a buy rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price lowered by Susquehanna from $57.00 to $51.00. The firm currently has a positive rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price trimmed by TD Cowen from $55.00 to $35.00. TD Cowen currently has a buy rating on the stock.
Vertical Aerospace (NYSE:EVTL) had its target price reduced by Needham & Company LLC from $11.00 to $5.00. The firm currently has a buy rating on the stock.
First Community (NASDAQ:FCCO) had its price target raised by Hovde Group from $36.00 to $37.50. Hovde Group currently has an outperform rating on the stock.
Fervo Energy (NASDAQ:FRVO) had its target price trimmed by Robert W. Baird from $50.00 to $35.00. The firm currently has an outperform rating on the stock.
Forward Industries (NASDAQ:FWDI) had its price target boosted by Cantor Fitzgerald from $7.90 to $8.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Forward Industries (NASDAQ:FWDI) had its price target lowered by B. Riley Financial, Inc. from $8.00 to $7.00. The firm currently has a buy rating on the stock.
Global-e Online (NASDAQ:GLBE) had its target price boosted by Morgan Stanley from $44.00 to $46.00. They currently have an equal weight rating on the stock.
Gaming and Leisure Properties (NASDAQ:GLPI) had its price target increased by Scotiabank from $49.00 to $50.00. The firm currently has a sector perform rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target boosted by Morgan Stanley from $7.00 to $11.00. They currently have an equal weight rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target raised by Wells Fargo & Company from $9.00 to $11.00. They currently have an equal weight rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its target price cut by Wells Fargo & Company from $1.75 to $1.50. Wells Fargo & Company currently has an equal weight rating on the stock.
Humacyte (NASDAQ:HUMA) had its price target cut by Benchmark Co. from $2.00 to $1.00. They currently have a speculative buy rating on the stock.
Hyperion DeFi (NASDAQ:HYPD) had its target price raised by Cantor Fitzgerald from $6.60 to $7.10. They currently have an overweight rating on the stock.
International Seaways (NYSE:INSW) had its target price boosted by Jefferies Financial Group Inc. from $100.00 to $108.00. They currently have a buy rating on the stock.
Jumia Technologies (NYSE:JMIA) had its price target trimmed by Cantor Fitzgerald from $16.00 to $11.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Kayne Anderson BDC (NYSE:KBDC) had its price target lowered by Royal Bank Of Canada from $16.00 to $15.00. The firm currently has an outperform rating on the stock.
Kura Oncology (NASDAQ:KURA) had its target price boosted by Wedbush from $36.00 to $38.00. Wedbush currently has an outperform rating on the stock.
Liftoff Mobile (NASDAQ:LFTO) had its target price trimmed by Cantor Fitzgerald from $33.00 to $32.00. The firm currently has an overweight rating on the stock.
Legal & General Group (LON:LGEN) had its target price lowered by JPMorgan Chase & Co. from GBX 285 to GBX 270. They currently have an underweight rating on the stock.
LENSAR (NASDAQ:LNSR) had its price target increased by BTIG Research from $7.00 to $9.00. The firm currently has a buy rating on the stock.
Liquidia (NASDAQ:LQDA) had its price target boosted by Bank of America Corporation from $79.00 to $92.00. The firm currently has a neutral rating on the stock.
Marathon Digital (NASDAQ:MARA) had its target price increased by Morgan Stanley from $5.50 to $6.00. They currently have an underweight rating on the stock.
MBIA (NYSE:MBI) had its price target trimmed by Keefe, Bruyette & Woods from $7.50 to $7.00. The firm currently has an outperform rating on the stock.
MongoDB (NASDAQ:MDB) had its target price boosted by Royal Bank Of Canada from $395.00 to $515.00. Royal Bank Of Canada currently has an outperform rating on the stock.
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target increased by HC Wainwright from $45.00 to $50.00. HC Wainwright currently has a buy rating on the stock.
Merit Medical Systems (NASDAQ:MMSI) had its target price raised by Bank of America Corporation from $92.00 to $97.00. The firm currently has a neutral rating on the stock.
MNTN (NYSE:MNTN) had its price target lowered by Tigress Financial from $26.00 to $22.00. They currently have a strong-buy rating on the stock.
Marex Group plc Ordinary Shares (NASDAQ:MRX) had its price target increased by Keefe, Bruyette & Woods from $80.00 to $90.00. They currently have an outperform rating on the stock.
Madison Square Garden Entertainment (NYSE:MSGE) had its price target increased by Susquehanna from $80.00 to $103.00. They currently have a positive rating on the stock.
Madison Square Garden Entertainment (NYSE:MSGE) had its target price boosted by JPMorgan Chase & Co. from $75.00 to $83.00. The firm currently has a neutral rating on the stock.
Matador Resources (NYSE:MTDR) had its price target boosted by Wells Fargo & Company from $63.00 to $79.00. The firm currently has an equal weight rating on the stock.
Matador Resources (NYSE:MTDR) had its target price trimmed by KeyCorp from $73.00 to $68.00. They currently have an overweight rating on the stock.
Manitowoc (NYSE:MTW) had its target price raised by Wells Fargo & Company from $10.00 to $12.00. The firm currently has an underweight rating on the stock.
Nebius Group (NASDAQ:NBIS) had its target price increased by Robert W. Baird from $250.00 to $340.00. The firm currently has an outperform rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by Morgan Stanley from $196.00 to $182.00. The firm currently has an equal weight rating on the stock.
Nexxen International (NASDAQ:NEXN) had its price target boosted by Scotiabank from $11.00 to $13.00. Scotiabank currently has a sector outperform rating on the stock.
Nexxen International (NASDAQ:NEXN) had its price target increased by Royal Bank Of Canada from $11.00 to $13.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Nexxen International (NASDAQ:NEXN) had its target price increased by Canaccord Genuity Group Inc. from $11.00 to $13.00. The firm currently has a buy rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its target price lowered by JPMorgan Chase & Co. from $52.00 to $46.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Oscar Health (NYSE:OSCR) had its price target raised by Wells Fargo & Company from $20.00 to $27.00. They currently have an equal weight rating on the stock.
Public Service Enterprise Group (NYSE:PEG) had its target price cut by Truist Financial Corporation from $90.00 to $84.00. The firm currently has a hold rating on the stock.
Performance Food Group (NYSE:PFGC) had its target price reduced by TD Cowen from $128.00 to $120.00. TD Cowen currently has a buy rating on the stock.
Pharvaris (NASDAQ:PHVS) had its target price boosted by Royal Bank Of Canada from $51.00 to $52.00. The firm currently has an outperform rating on the stock.
Pharvaris (NASDAQ:PHVS) had its price target increased by Citizens Jmp from $74.00 to $75.00. The firm currently has a market outperform rating on the stock.
Fidelis Insurance (NYSE:PLGO) had its target price raised by Citizens Jmp from $28.00 to $29.00. Citizens Jmp currently has a market outperform rating on the stock.
Fidelis Insurance (NYSE:PLGO) had its target price lowered by Barclays PLC from $24.00 to $23.00. Barclays PLC currently has an equal weight rating on the stock.
Red Robin Gourmet Burgers (NASDAQ:RRGB) had its target price increased by Benchmark Co. from $8.00 to $10.00. They currently have a buy rating on the stock.
Riskified (NYSE:RSKD) had its target price boosted by Keefe, Bruyette & Woods from $5.50 to $6.25. The firm currently has a market perform rating on the stock.
Standard Life (LON:SDLF) had its price target raised by JPMorgan Chase & Co. from GBX 975 to GBX 1,075. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Spruce Biosciences (NASDAQ:SPRB) had its price target reduced by Citizens Jmp from $150.00 to $144.00. They currently have a market outperform rating on the stock.
Sprout Social (NASDAQ:SPT) had its target price boosted by Morgan Stanley from $10.00 to $11.00. Morgan Stanley currently has an equal weight rating on the stock.
Scholar Rock (NASDAQ:SRRK) had its target price raised by JPMorgan Chase & Co. from $56.00 to $63.00. They currently have an overweight rating on the stock.
STAAR Surgical (NASDAQ:STAA) had its price target trimmed by Wedbush from $40.00 to $37.00. The firm currently has an outperform rating on the stock.
Sutro Biopharma (NASDAQ:STRO) had its target price cut by Citizens Jmp from $41.00 to $34.00. The firm currently has a market outperform rating on the stock.
Teledyne Technologies (NYSE:TDY) had its price target raised by Morgan Stanley from $680.00 to $715.00. They currently have an equal weight rating on the stock.
First Tracks Biotherapeutics (NASDAQ:TRAX) had its price target raised by Wedbush from $60.00 to $70.00. Wedbush currently has an outperform rating on the stock.
Trimble (NASDAQ:TRMB) had its target price increased by JPMorgan Chase & Co. from $75.00 to $76.00. They currently have an overweight rating on the stock.
Versigent (NYSE:VGNT) had its price target raised by Argus from $50.00 to $54.00. They currently have a buy rating on the stock.
Vestis (NYSE:VSTS) had its price target raised by JPMorgan Chase & Co. from $11.00 to $13.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
W.P. Carey (NYSE:WPC) had its target price increased by Scotiabank from $76.00 to $77.00. The firm currently has a sector perform rating on the stock.
Westport Fuel Systems (NASDAQ:WPRT) (TSE:WPRT) had its price target lowered by Royal Bank Of Canada from $1.75 to $1.00. They currently have a sector perform rating on the stock.
Williams-Sonoma (NYSE:WSM) had its target price raised by Telsey Advisory Group from $225.00 to $255.00. Telsey Advisory Group currently has an outperform rating on the stock.
Wolverine World Wide (NYSE:WWW) had its target price raised by Needham & Company LLC from $21.00 to $24.00. Needham & Company LLC currently has a buy rating on the stock.
Receive News & Ratings for Advance Auto Parts Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advance Auto Parts Inc and related companies with MarketBeat.com's FREE daily email newsletter.
